AbCellera
2012
FOUNDED
PRIVATE
STATUS
71-80
EMPLOYEES
Series A
LATEST DEAL TYPE
$10M
LATEST DEAL AMOUNT
7
INVESTORS
Description
Developer of monoclonal antibodies designed to accelerate the discovery and development of next-generation antibody therapies. The company's platform partners with pharmaceutical and biotech for therapeutic antibody discovery and immune profiling, increasing the speed and efficiency of antibody discovery from natural immune responses of immunized animals and human patients, enabling new avenues for human immune profiling and infectious disease research, with the potential to accelerate the development of urgently needed diagnostic tests and vaccines.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- 2215 Yukon Street
- Vancouver, British Columbia V5Y 0A1
- Canada
+1 (604) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore AbCellera’s full profile, request a free trial.
AbCellera Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 27-Sep-2018 | $10M | 0000 | Completed | Generating Revenue | |
| 5. Grant | 25-Jan-2018 | Completed | Generating Revenue | |||
| 4. Grant | 19-Jan-2017 | Completed | Generating Revenue | |||
| 3. Grant | 26-Jun-2015 | 00000 | Completed | Startup | ||
| 2. Seed Round | 09-Aug-2014 | Completed | Startup | |||
| 1. Grant | 27-Sep-2013 | $62K | Completed | Startup |
AbCellera Competitors (53)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fate Therapeutics | Formerly VC-backed | San Diego, CA | 000 | 00000 | 00000000000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | La Jolla, CA | 00000 | 00000000000 | 00000 | |
| 00000000 000000000 | Formerly VC-backed | Cambridge, MA | 000 | 0000 | 000000000 | 0000 |
| 000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000 000000000000 | Venture Capital-Backed | Basel, Switzerland | 00.000 | 00000000000 | 00.000 |
AbCellera Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 0000000000 | 01-Aug-2018 | 000000000000000000 | Other Pharmaceuticals and Biotechnology | 0000 000000 00.0 |
AbCellera Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Data Collective | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Brain Canada | Government | 000 0000 | 000000 0 | |||
| CQDM | Government | 000 0000 | 000000 0 | |||
| Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | 000 0000 | 000000 0 | |||
| Western Economic Diversification Canada | Government | 000 0000 | 000000 0 |
AbCellera Executive Team (9)
2 Former Executives
You’re viewing 5 of 9 executives. Get the full list »AbCellera Board Members (6)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Carl Hansen Ph.D | AbCellera | Co-Founder, President, Chief Executive Officer & Board Member | 000 0000 | |
| John Hamer Ph.D | Data Collective | Board Member | 000 0000 | |
| Michael Hayden Ph.D | Self | Board Member | 000 0000 | |
| Veronique Lecault | AbCellera | Co-Founder, Executive of Corporate Development & Board Member | 000 0000 |
2 Former Board Members
You’re viewing 4 of 6 board members. Get the full list »